Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel
Authors:
- Daniel M. WeinbergerDWDaniel M. Weinberger
- Noga Givon-LaviNGNoga Givon-Lavi
- Yonat Shemer-AvniYSYonat Shemer-Avni
- Jacob Bar-ZivJBJacob Bar-Ziv
- Wladimir J. AlonsoWAWladimir J. Alonso
- David GreenbergDGDavid Greenberg
- Ron DaganRDRon Dagan
Open Access
- 1 July 2013
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 19 (7) , 1084-1091
Abstract
Postlicensure surveillance of pneumonia incidence can be used to estimate whether pneumococcal conjugate vaccines (PCVs) affect incidence. We used Poisson regression models that control for baseline seasonality to determine the impact of PCVs and the possible effects of variations in virus activity in Israel on these surveillance estimates. PCV was associated with significant declines in radiologically confirmed alveolar pneumonia (RCAP) among patients <6 months, 6–17 months, and 18–35 months of age (–31% [95% CI –51% to –15%], –41% [95% CI –52 to –32%], and –34% [95% CI –42% to –25%], respectively). Respiratory syncytial virus (RSV) activity was associated with strong increases in RCAP incidence, with up to 44% of cases attributable to RSV among infants <6 months of age and lower but significant impacts in older children. Seasonal variations, particularly in RSV activity, masked the impact of 7-valent PCVs, especially for young children in the first 2 years after vaccine introduction.Keywords
This publication has 23 references indexed in Scilit:
- Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in IsraelVaccine, 2012
- Pneumococcal Coinfection with Human MetapneumovirusThe Journal of Infectious Diseases, 2006
- The Impact of a 9-Valent Pneumococcal Conjugate Vaccine on the Public Health Burden of Pneumonia in HIV-Infected and -Uninfected ChildrenClinical Infectious Diseases, 2005
- A role for Streptococcus pneumoniae in virus-associated pneumoniaNature Medicine, 2004
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003
- A Decade (1989–1998) of Pediatric Invasive Pneumococcal Disease in 2 Populations Residing in 1 Geographic Location: Implications for Vaccine ChoiceClinical Infectious Diseases, 2001
- Bacterial Vaccines and Serotype Replacement: Lessons from Haemophilus influenzae and Prospects for Streptococcus pneumoniaeEmerging Infectious Diseases, 1999
- Population Attributable Fraction Estimation for Established Breast Cancer Risk Factors: Considering the Issues of High Prevalence and UnmodifiabilityAmerican Journal of Epidemiology, 1998
- Hospitalizations for infectious diseases in Jewish and Bedouin children in southern IsraelEuropean Journal of Epidemiology, 1998
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991